Core Viewpoint - The article discusses the biological mechanisms behind weight gain in middle age, particularly focusing on the role of a specific type of fat precursor cell, CP-A, which becomes more active with aging and contributes to abdominal fat accumulation [7][12][24]. Group 1: Mechanisms of Weight Gain - Traditional views suggest that fat cell numbers remain constant after adulthood, with weight gain primarily due to the enlargement of existing fat cells. However, recent studies indicate that new fat cells are generated in significant numbers, especially in middle age [9][10]. - Research on mice shows that as they reach middle age (approximately 9-12 months), the number of new fat cells generated in the visceral fat area significantly increases compared to younger mice [10]. Group 2: Role of CP-A Cells - The study identifies CP-A cells, a specific type of fat precursor cell, as a major contributor to fat accumulation in middle age. These cells become dominant in visceral fat tissue as aging progresses [12][15]. - In young mice, CP-A cells are nearly absent, but they rapidly increase in number in middle-aged mice, comprising 34.23% of the visceral white fat tissue [15]. Group 3: Mechanisms of CP-A Cell Activity - CP-A cells exhibit enhanced proliferation and differentiation capabilities, with their proliferation rate being 2.5 times that of young fat precursor cells. They also show a fourfold increase in the ability to generate new fat cells compared to similar cells from younger mice [17][19]. - The article highlights that even in a young mouse environment, CP-A cells can produce five times more fat cells than their younger counterparts [19]. Group 4: Potential Interventions - The LIFR (leukemia inhibitory factor receptor) signaling pathway is identified as a potential target for intervention. High expression levels of LIFR in CP-A cells suggest it plays a crucial role in their proliferation and fat generation [20][23]. - Experiments show that inhibiting LIFR significantly reduces fat generation in CP-A cells while having little effect on young fat precursor cells, indicating a unique dependency of CP-A on LIFR signaling [22][24]. Group 5: Conclusion - The increase in visceral fat in middle age is attributed not just to metabolic issues but to the proliferation of new fat cells, particularly CP-A cells. Targeting LIFR may offer a new strategy to combat stubborn abdominal fat in middle-aged individuals [24][25].

Core Viewpoint - The article discusses a recent study published in *Science* that reveals the underlying biological mechanisms contributing to abdominal fat accumulation in middle-aged individuals, particularly focusing on a specific type of fat cell that becomes more active with age [5][10]. Group 1: Mechanisms of Fat Accumulation - The study indicates that the increase in abdominal fat in middle-aged individuals is primarily due to the generation of new fat cells rather than the enlargement of existing ones, challenging the previous belief that fat cell numbers remain constant after adulthood [7]. - Researchers found that a specific subgroup of fat precursor cells, known as CP-A, significantly increases in number and activity in middle-aged mice, accounting for 34.23% of the visceral white adipose tissue [8][10]. - The proliferation and differentiation capabilities of CP-A cells are four times greater than those of another type of precursor cell, CP-1, indicating that CP-A plays a crucial role in the accumulation of visceral fat in middle age [9]. Group 2: Role of LIFR in Fat Cell Generation - The study identifies LIFR (leukemia inhibitory factor receptor) as a key gene that is highly expressed in CP-A cells and is associated with aging and fat generation [12]. - Inhibition of LIFR using a specific inhibitor (EC359) resulted in a 60% reduction in fat generation from CP-A cells, while having minimal effect on CP-1 cells, highlighting the dependency of CP-A on LIFR signaling [15]. - The activation of the JAK-STAT3 signaling pathway by LIFR is crucial for the proliferation and fat-generating capabilities of CP-A cells, suggesting that targeting LIFR could be a potential strategy to mitigate abdominal fat accumulation in middle-aged individuals [15].